Latest news
Oculis to Acquire Full Rights to Privosegtor in Asset Deal with Accure Therapeutics - TipRanksTipRanks · Mon, 10 Aug 2026 13:04:03 GMTOculis signs asset deal with Accure Therapeutics for privosegtor - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:33:45 GMTTech ROUNDUP: Accure, Hydrostor, Shoals and TerraFlow, and Qnetic advance energy storage tech - Energy-Storage.NewsEnergy-Storage.News · Mon, 10 Aug 2026 12:29:32 GMTOculis Holding (OCS) inks $3.8M cash-plus-shares deal for Privosegtor rights - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:34 GMTOculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 08:45:17 GMTNovonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 07:36:21 GMTOculis to buy Accure rights to Privosegtor for $3.8 million plus up to 2,050,000 shares - BitgetBitget · Mon, 10 Aug 2026 07:27:12 GMTOculis Signs Asset Purchase Agreement with Accure - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 07:01:50 GMT